1NC2 | date | |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | CL, DOE, NAG, PCA, YT3 | enzyme |
| ||||||||||||
related structures | by homologous chain: 1IND, 1MFD, 1NDM | ||||||||||||||
Primary reference | Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system., Corneillie TM, Fisher AJ, Meares CF, J Am Chem Soc 2003 Dec 10;125(49):15039-48. PMID:14653738 |
Data retrieval |
View 1NC2 in 3D |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |